Biogen Idec (www.biogenidec.com; Cambridge, MA) will team up with a joint venture of Italy's Telethon Foundation and the San Raffaele Hospital and Scientific Institute to develop gene therapies for hemophilia A and B-a collaboration that deepens the biotech giant's presence in battling the bleeding disorders.
展开▼
